Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice

Immunology

Volumn 103, Issue 1, 2001, Pages 90-97

  Oka, Yuichiro ^a   Fazle Akbar, S M ^a   Horiike, Norio ^a   Joko, Kouji ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; DENDRITIC CELL; DNA VECTOR; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; DENDRITIC CELLS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; SPLEEN; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

EID: 0035014396     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01202.x     Document Type: Article

References (26)

1. Peters M, Vierling J, Grenshwin ME, Millich D, Chisari FV, Hoofnagle JH. Immunology and the liver. Hepatology 1991; 13:977-94.
2. Bloom BS, Hillman AL, Fendrick AM, Schwartz JS. A reapprisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis. Ann Intern Med 1993; 118:298-306.
3. Pol S, Driss F, Michel M, Nalpes B, Berthelot P, Brechot C. Specific vaccine therapy in chronic hepatitis B infection. Lancet (Letter) 1994; 344:342.
4. Wen Y-M, Wu X-H, Hu D-C, Zhang Q-P, Guo S-Q. Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy. Lancet (Letter) 1995; 345:1575-6.
5. Akbar SMF, Kajino K, Tanimoto T, Kurose K, Masumoto T, Michitaka K, Horiike N, Onji M. Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J Hepatol 1997; 26:131-7.
6. Akbar SMF, Horiike N, Onji M. Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier. Immunology 1999; 96:98-108.
7. Akbar SMF, Abe M, Masumoto T, Horiike N, Onji M. Mechanism of action of vaccine therapy in murine hepatitis B virus carrier: vaccine-induced activation of antigen presenting dendritic cells. J Hepatol 1999; 30:755-64.
8. Akbar SMF, Yamamoto K, Abe M et al. Potent synergistic effect of sho-saiko-to (TJ-9), a herbal medicine during vaccine therapy in a murine model of hepatitis B virus (HBV) -carrier. Eur J Clin Invest 1999; 29:786-92.
9. Pourcelli C, Tiollais P, Farza H. Transcription of the S gene in transgenic mice is associated with hypomethylation at specific sites and with DNase 1 sensitivity. J Virol 1990; 64:931-5.
10. Kadchouel M, Farza H, Simon D, Tiollais P, Pourcel C. Maternal inhibition of hepatitis B surface antigen gene expression in transgenic mice correlates with de novo methylation. Nature 1987; 329:454-6.
11. Geissler M, Schirmbeck R, Reimann J, Blum HE, Wands JR. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral responses to the middle but not to the large hepatitis B virus surface antigen in mice. Hepatology 1998; 28:202-9.
12. Chow Y-H, Huang W-L, Chi W-K, Chu Y-D, Tao M-H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 1997; 71:169-78.
13. Geissler M, Tokushige K, Chante CC, Zurawski VR, Wands JR. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology 1997; 112:1307-20.
14. Michel M-L, Davis HL, Schileef M, Mancini M, Tiollais P, Whalen RG. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 1995; 92:5307-11.
15. Davis HL, Mancini M, Michel M-L, Whalen RG. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 1996; 14:910-5.
16. Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel M-L. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci USA 1996; 93:496-501.
17. Davis HL, Millan CLB, Mancini M et al. DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice. Vaccine 1997; 15:849-52.
18. Araki K, Miyazaki J, Hino O, Tomita N, Chisaka O, Matsubara K, Yamamura K. Expression and replication of hepatitis B virus genome in transgenic mice. Proc Natl Aca Sci USA 1989; 86:207-11.
19. Niwa H, Yamamura K-I, Miyazaki J-I. Efficient selection for high expression transfectants with a novel eukaryotic vector. Gene 1991; 108:192-200.
20. Akbar SMF, Inaba K, Onji M. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by γ-interferon: abrogation of immune response defect to a T-cell- dependent antigen. Immunology 1996; 87:519-27.
21. Akbar SMF, Onji M, Inaba K, Yamamura K, Ohta Y. Low responsiveness of hepatitis B virus transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen presenting activity of dendritic cells. Immunology 1993; 78:468-73.
22. Tanimoto K, Akbar SMF, Michitaka K, Onji M. Immunohistochemical localization of antigen presenting cells in liver from patients with primary biliary cirrhosis; highly restricted distribution of CD83 positive activated dendritic cells. Pathol Res Pract 1999; 195:157-62.
23. Chen S, Akbar SMF, Tanimoto K, Ninomiya T, Iuchi H, Michitaka K, Horiike N, Onji M. Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis. Cancer Lett 1999; 148:48-57.
24. Davis HL, Michel M-L, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 1993; 2:1847-51.
25. Davis HL, Michel M-L, Mancini M, Schleef M, Whalen RG. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 1994; 12:1503-9.
26. Akbari O, Panjwani N, Garcia S, Tascon R, Lowrie D, Stockinger B. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J Exp Med 1999; 189:169-77.